Creabilis Therapeutics viene acquisita dall’americana Sienna Biopharmaceuticals
Creabilis Therapeutics viene acquisita per 150 milioni di dollari da Sienna Biopharmaceuticals, i laboratori di ricerca restano in Italia, al Bioindustry Park.
Creabilis Therapeutics viene acquisita per 150 milioni di dollari da Sienna Biopharmaceuticals, i laboratori di ricerca restano in Italia, al Bioindustry Park.
Bioindustry Park Silvano Fumero S.p.A. Società Benefit
Via Ribes, 5 – 10010 – Colleretto Giacosa (TO) – Italia
Phone: +39 0125 561311 – Fax: +39 0125 538350 Email: info@bioindustrypark.it
Copyright © 2022 Bioindustry Park Silvano Fumero S.p.A. Società Benefit
Fax code, VAT registration and CCIAA number 06608260011
Commercial Register of Turin n. 799.923
Share Capital Euro 12.581.663 iv
Website designed and developed by Studioata
Bioindustry Park Silvano Fumero
| Cookie | Durata | Descrizione |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |